SenzaGen
  • Home
  • Services
    • At a glance
      • Explore our services
      • Who we work with
      • GLP
    • GARD: Skin and Respiratory Sensitization Testing
      • GARDskin: OECD TG 442E
      • GARDpotency: OECD TGP 4.106
      • GARDskin Medical Device: ISO 10993-10
      • GARDskin Dose-Response
      • GARDair
      • “Difficult-to-test” samples
    • Regulatory Toxicity Testing
      • Skin corrosion: OECD TG 431
      • Skin irritation: OECD TG 439
      • Skin sensitization: OECD TG 442C, 442D, 442E
      • Skin absorption: OECD TG 428
      • Eye irritation: OECD TG 492, 492B
      • Phototoxicity: OECD TG 432, 498
      • Genotoxicity: OECD TG 471, 487
      • Full list of regulatory tests
    • Medical Device Services
      • Biological evaluation
      • Biocompatibility testing
        • Cytotoxicity: ISO 10993-5
        • Irritation: ISO 10993-23
        • Skin sensitization: ISO 10993-10
      • Substance-based Medical Devices
        • Qualification — Mode of Action
        • Classification — ADME
      • Advisory
    • Toxicology Advisory
      • Areas of expertise
      • The team
      • Medical Devices
      • Cosmetics
      • Chemicals
      • Pharmaceuticals
  • Science
    • GARD Technology
    • Science Behind
    • Scientific Publications
    • Posters
    • Webinars
  • Company
    • About Us
    • Sustainability
    • Career
    • Partners
  • Investors
    • SenzaGen at a Glance
    • Financial Reports
    • Press Releases
    • The Share
    • Analyst Coverage
    • Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Auditor
      • Nomination Committee
      • Annual General Meeting
    • Calendar
    • Prospekt / Emission
  • News and Events
    • Press Releases
    • News Posts
    • Event Calendar
  • Contact
  • Get a quote
  • Search
  • Menu Menu

SenzaGen’s Newsletter October 2023

5 October, 2023

Click image to view the newsletter in browser.

Share this entry
  • Share on Facebook
  • Share on X
  • Share on WhatsApp
  • Share on LinkedIn
  • Share on Vk
  • Share on Reddit
  • Share by Mail
https://senzagen.com/wp-content/uploads/2020/07/News.png 133 146 Tina Dackemark Lawesson https://senzagen.com/wp-content/uploads/2017/01/LoggaSquare_RGB_liten_HF.png Tina Dackemark Lawesson2023-10-05 13:43:292023-10-24 13:47:46SenzaGen’s Newsletter October 2023

Quick Links

Contact
Privacy Policy (En)
Privacy Policy (Sv)
General Terms and Conditions

Pages

  • Home
  • Services
  • Investors
  • Contact
  • News and Events

Follow Us

SUBSCRIBE TO PRESS RELEASES

Using in vitro data for regulatory approval of medical devices according to...SenzaGen presented at the BioStock Life Science Fall Summit in Lund on October...
Scroll to top

Subscribe


Prenumerera